WeVote
Log In

Bill

Bill

A 11598

Relates to warning labels on certain sports and muscle creams

2025 Regular Session

Arielle's Law requires warning labels on sports or muscle creams containing methyl salicylate, stating the ingredient, directed use, and physician consultation.

REFERRED TO CONSUMER AFFAIRS AND PROTECTION
0
WeVote Research Nonpartisan
Bill Summary · A 11598

Overview

Arielle's Law (A11598) is a New York bill introduced in the 2025-2026 session that would require warning labels on certain sports and muscle creams containing methyl salicylate. The act would add a new provision to the General Business Law and impose civil penalties for violations. The measure is currently referred to the Committee on Consumer Affairs and Protection.

Purpose and intent

  • To prevent consumer harm by ensuring visibility of safety information on sports and muscle creams that contain methyl salicylate.
  • To inform purchasers that the product should be used only as directed and that a physician should be consulted prior to use.

Key provisions

  • New law added: General Business Law § 391-x (Sale or promotional distribution of sports or muscle cream containing methyl salicylate).
    • Requirement: Any sale, offer to sell, or promotional distribution of sports or muscle creams containing methyl salicylate must display a warning label.
    • Label content (as required by the bill):
    • The product contains methyl salicylate.
    • The product should be used only as directed.
    • A physician should be consulted prior to use.
  • Penalty for non-compliance: Civil penalty up to $500 for each violation.
  • Effective date: Immediate upon enactment.

Who/what is affected

  • Entities involved in selling, offering for sale, or distributing sports or muscle creams that contain methyl salicylate (e.g., retailers, manufacturers, distributors, and promotional promoters).
  • Consumers who purchase or receive these products with the required warning label.

Procedural and timeline aspects

  • Introduction and referral: Introduced and referred to the Committee on Consumer Affairs and Protection on June 5, 2026.
  • Status: Pending committee action (as of the latest information in the text).

Potential impact

  • Increased consumer awareness regarding the presence of methyl salicylate in certain creams.
  • Potential administrative and labeling compliance costs for retailers and manufacturers.
  • A measurable enforcement mechanism via civil penalties, incentivizing adherence to labeling requirements.

Notes

  • The bill is labeled as an act to be known as “Arielle's Law.”
  • The text specifies a straightforward labeling requirement and a relatively modest per-violation fine, with no additional penalties or regulatory processes described beyond the civil penalty.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.